Skip to main content

Table 3 Change and percentage change (in% by weight) in selected fatty acids and fatty acid ratios of interest between Day 0 and Day 28, by treatment, with statistical significance

From: A randomized clinical trial to determine the efficacy of manufacturers’ recommended doses of omega-3 fatty acids from different sources in facilitating cardiovascular disease risk reduction

Treatment AA EPA DPA DHA EPA + DHA AA:EPA EPA + DPA + DHA ω -3 FA ω -6 FA ω-3:ω-6 Ratio ω-6:ω-3 Ratio
Δ % Δ Δ % Δ Δ % Δ Δ % Δ Δ % Δ Δ % Δ Δ % Δ Δ % Δ Δ % Δ Δ % Δ Δ % Δ
rTG mean -0.551 -3.27 1.469 151.1*** 0.251 22.8** 1.177 44.6*** 2.646 69.8*** -7.148 -56.7*** 2.903 56.9*** 2.807 47.5*** -2.626 -5.78** 0.080 57.6*** -2.507 -34.4***
rTG SD 1.770 14.60 0.691 102.69 0.312 28.01 0.628 36.49 1.150 44.37 4.271 13.62 1.218 34.63 1.244 28.671 3.889 8.970 0.033 30.403 1.342 11.366
EE mean -0.316 -0.98 1.384 155.0*** 0.189 17.0* 0.255 12.90 1.638 47.5*** -7.107 -54.3*** 1.824 39.4*** 1.826 33.9*** -1.572 -3.200 0.050 37.4*** -1.888 -24.7***
EE SD 2.207 19.54 0.847 123.65 0.273 24.74 0.656 31.80 1.365 49.05 4.745 18.13 1.521 41.46 1.497 34.923 4.153 9.537 0.029 28.093 1.413 13.871
PL mean -0.260 -0.73 0.293 34.9* 0.150 14.5* 0.194 8.93 0.487 14.5* -2.740 -17.2* 0.637 13.5*** 0.523 10.200 -1.450 -2.720 0.017 13.2* -0.782 -10.2*
PL SD 1.876 16.32 0.528 45.48 0.290 24.65 0.512 20.08 0.874 23.43 4.109 34.78 0.974 19.14 1.131 18.698 4.559 10.214 0.024 16.039 0.921 12.839
TG mean -0.353 0.24 0.294 35.7** 0.014 4.37 0.447 18.9* 0.740 21.3** -2.606 -17.9* 0.751 16.6*** 0.752 14.2** -0.703 -0.628 0.020 13.4* -0.815 -11.4**
TG SD 2.206 20.22 0.493 43.34 0.301 21.60 0.596 27.34 0.866 25.65 4.249 34.61 1.118 23.20 1.161 20.229 4.509 10.030 0.020 12.827 0.791 11.331
  1. ∆ = change; %∆ = percent change; SD = Standard deviation; ***p-value - <0.0001 - <0.001; **p-value 0.001 – <0.01; ***p-value 0.01 – < 0.05.